BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3106259)

  • 1. Low-dose aurothioglucose in pemphigus vulgaris.
    Frumkin A
    Isr J Med Sci; 1986 Dec; 22(12):903-5. PubMed ID: 3106259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of pemphigus with gold compounds: a long-term follow-up report.
    Penneys NS; Eaglstein WH; Frost P
    Arch Dermatol; 1976 Feb; 112(2):185-7. PubMed ID: 822783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gold: an old drug still working in refractory pemphigus.
    Iranzo P; Alsina MM; Martínez-De Pablo I; Segura S; Mascaró JM; Herrero C
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):902-7. PubMed ID: 17658998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids.
    Werth VP
    Arch Dermatol; 1996 Dec; 132(12):1435-9. PubMed ID: 8961871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood pemphigus treated with gold.
    Paltzik RL; Laude TA
    Arch Dermatol; 1978 May; 114(5):768-9. PubMed ID: 348118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases.
    Mahajan VK; Sharma NL; Sharma RC; Garg G
    Int J Dermatol; 2005 Oct; 44(10):821-7. PubMed ID: 16207182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a gold compound for the treatment of pemphigus foliaceus in a foal.
    Power HT; McEvoy EO; Manning TO
    J Am Vet Med Assoc; 1982 Feb; 180(4):400-3. PubMed ID: 6800993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pemphigus vulgaris: results of treatment with gold as a steroid-sparing agent in a series of thirteen patients.
    Poulin Y; Perry HO; Muller SA
    J Am Acad Dermatol; 1984 Nov; 11(5 Pt 1):851-7. PubMed ID: 6439764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aurothioglucose in rheumatoid arthritis. Outcome of treatment in patients intolerant of sodium aurothiomalate.
    McGirr EE; Browne CD; Champion GD; Day RO; Sambrook PN
    Med J Aust; 1984 Sep; 141(6):349-51. PubMed ID: 6438454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An alternate-day corticosteroid regimen for pemphigus vulgaris. A 13-year prospective study.
    Chaidemenos GCh; Mourellou O; Koussidou T; Tsatsou F
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1386-91. PubMed ID: 17958846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of pemphigus vulgaris by azathioprine and low doses of prednisone (Lever scheme)].
    Benoit Corven C; Carvalho P; Prost C; Verret JL; Saiag P; Noblesse I; Bedane C; Chosidow O; Young P; Roujeau JC; Joly P
    Ann Dermatol Venereol; 2003 Jan; 130(1 Pt 1):13-5. PubMed ID: 12605150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved protocol for treatment of pemphigus vulgaris with protein A immunoadsorption.
    Shimanovich I; Herzog S; Schmidt E; Opitz A; Klinker E; Bröcker EB; Goebeler M; Zillikens D
    Clin Exp Dermatol; 2006 Nov; 31(6):768-74. PubMed ID: 16824051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral gold therapy (Auranofin) in pemphigus vulgaris.
    Salomon D; Saurat JH
    Dermatologica; 1986; 172(6):310-4. PubMed ID: 3089850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial.
    Mentink LF; Mackenzie MW; Tóth GG; Laseur M; Lambert FP; Veeger NJ; Cianchini G; Pavlovic MD; Jonkman MF
    Arch Dermatol; 2006 May; 142(5):570-6. PubMed ID: 16702494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of corticosteroids and aurothioglucose in a pygmy goat with pemphigus foliaceus.
    Valdez RA; Gelberg HB; Morin DE; Zuckermann FA
    J Am Vet Med Assoc; 1995 Sep; 207(6):761-5. PubMed ID: 7657579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin therapy in the treatment of patients with pemphigus vulgaris unresponsive to conventional immunosuppressive treatment.
    Ahmed AR
    J Am Acad Dermatol; 2001 Nov; 45(5):679-90. PubMed ID: 11606916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of pemphigus vulgaris.
    Kavusi S; Daneshpazhooh M; Farahani F; Abedini R; Lajevardi V; Chams-Davatchi C
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):580-4. PubMed ID: 18194237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High dose, low frequency parenteral gold administration.
    Norton WL; Donnelly RJ
    J Rheumatol; 1983 Jun; 10(3):454-8. PubMed ID: 6411920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of direct immunofluorescence in predicting remission in pemphigus vulgaris.
    Balighi K; Taheri A; Mansoori P; Chams C
    Int J Dermatol; 2006 Nov; 45(11):1308-11. PubMed ID: 17076711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gold treatment of pemphigus.
    Rapini RP
    J Am Acad Dermatol; 1985 Aug; 13(2 Pt 1):310. PubMed ID: 3930582
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.